Moors & Cabot, Inc. Isoray, Inc. Call Options Transaction History
Moors & Cabot, Inc.
- $1.85 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ISR
# of Institutions
4Shares Held
287KCall Options Held
0Put Options Held
0-
Ria Advisory Group LLC Ames, IA107KShares$73,7280.05% of portfolio
-
Bergan Kdv Wealth Management, LLC75KShares$51,7490.01% of portfolio
-
Portland Investment Counsel Inc. Burlington, A670KShares$48,3000.02% of portfolio
-
Jdm Financial Group LLC Encino, CA35KShares$24,1490.03% of portfolio
About Isoray, Inc.
- Ticker ISR
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 142,112,992
- Market Cap $98.1M
- Description
- Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...